Literature DB >> 2043918

Mechanisms contributing to the differential haemodynamic effects of bombesin and cholecystokinin in conscious, Long Evans rats.

P J Janssen1, S M Gardiner, A M Compton, T Bennett.   

Abstract

1. Long Evans rats were chronically instrumented with intravascular catheters and pulsed Doppler probes to assess changes in renal, mesenteric and hindquarters blood flows and vascular conductances in response to bombesin (2.5 micrograms kg-1, i.v.) and cholecystokinin (CCK) (0.5 and 5.0 micrograms kg-1, i.v.). 2. Bombesin caused an increase in heart rate and blood pressure, together with a transient renal vasoconstriction and prolonged mesenteric vasodilatation; there was an early hindquarters vasodilatation followed by vasoconstriction. 3. In the presence of phentolamine, bombesin caused a fall in blood pressure due to enhanced hindquarters vasodilatation; these effects were reversed by propranolol and hence were possibly due to circulating adrenaline acting on vasodilator beta 2-adrenoceptors. 4. During concurrent administration of phentolamine, propranolol and atropine, bombesin caused prolonged tachycardia and a rise in blood pressure. The renal vasoconstrictor and mesenteric vasodilator effects of bombesin were not reduced under these conditions and thus probably were direct and/or indirect non-adrenergic, non-cholinergic (NANC) effects. 5. CCK caused dose-dependent increases in blood pressure accompanied by renal, mesenteric and hindquarters vasoconstriction followed, after the higher dose, by vasodilatations. The lower dose of CCK increased heart rate but there was a bradycardia followed by a tachycardia after the higher dose. 6. Experiments with antagonists as described above indicated the pressor effect of CCK was mediated largely through alpha-adrenoceptors, as were the mesenteric and hindquarters vasoconstrictor effects; CCK exerted NANC negative chronotropic effects. 7. All the effects of CCK were markedly inhibited by L364,718. This observation, and the finding that L364,718 had no effect on the responses to bombesin, together with the dissimilarities in the regional haemodynamic effects of exogenous CCK and bombesin, indicate that the cardiovascular actions of the latter were not dependent on the release of endogenous CCK.

Entities:  

Mesh:

Substances:

Year:  1991        PMID: 2043918      PMCID: PMC1917871          DOI: 10.1111/j.1476-5381.1991.tb12143.x

Source DB:  PubMed          Journal:  Br J Pharmacol        ISSN: 0007-1188            Impact factor:   8.739


  44 in total

1.  A role for the area postrema in mediating cholecystokinin-stimulated oxytocin secretion.

Authors:  D A Carter; S L Lightman
Journal:  Brain Res       Date:  1987-12-01       Impact factor: 3.252

2.  Chronotropic actions of cholecystokinin octapeptide on the rat heart.

Authors:  J D Marker; M L Roberts
Journal:  Regul Pept       Date:  1988-03

3.  Haematological changes induced by the intravenous injection of CCK-8 in rats subjected to haemorrhagic shock.

Authors:  S Guarini; C Bazzani; L Leo; A Bertolini
Journal:  Neuropeptides       Date:  1988 Feb-Mar       Impact factor: 3.286

4.  Regional hemodynamic responses to adrenoceptor antagonism in conscious rats.

Authors:  S M Gardiner; T Bennett
Journal:  Am J Physiol       Date:  1988-10

5.  Atropine- and endothelium-dependent relaxation.

Authors:  G Thomas; R Mostaghim; P W Ramwell
Journal:  Eur J Pharmacol       Date:  1988-01-19       Impact factor: 4.432

6.  Effect of continuous infusions of CCK-8 on food intake and body and pancreatic weights in rats.

Authors:  L Lukaszewski; M Praissman
Journal:  Am J Physiol       Date:  1988-01

7.  Friedman and Quade tests: BASIC computer program to perform nonparametric two-way analysis of variance and multiple comparisons on ranks of several related samples.

Authors:  E Theodorsson-Norheim
Journal:  Comput Biol Med       Date:  1987       Impact factor: 4.589

Review 8.  The discovery of nitric oxide as the endogenous nitrovasodilator.

Authors:  S Moncada; R M Palmer; E A Higgs
Journal:  Hypertension       Date:  1988-10       Impact factor: 10.190

9.  Positive chronotropic responses produced by alpha-adrenoreceptors in the pithed rat.

Authors:  L H Tung; M J Rand; O H Drummer; W J Louis
Journal:  J Auton Pharmacol       Date:  1982-12

Review 10.  Gastrin-releasing peptide (mammalian bombesin) gene expression in health and disease.

Authors:  M E Sunday; L M Kaplan; E Motoyama; W W Chin; E R Spindel
Journal:  Lab Invest       Date:  1988-07       Impact factor: 5.662

View more
  6 in total

1.  Mechanisms contributing to the regional haemodynamic effects of neurotensin in conscious, unrestrained Long Evans rats.

Authors:  H Bachelard; S M Gardiner; P A Kemp; T Bennett
Journal:  Br J Pharmacol       Date:  1992-01       Impact factor: 8.739

2.  Impact of vasoactive intestinal polypeptide and gastrin-releasing peptide on small bowel microcirculation and mucosal injury after hepatic ischemia/reperfusion in rats.

Authors:  Ingo Leister; J Sydow; T Stojanovic; L Füzesi; B Sattler; M Heuser; H Becker; P M Markus
Journal:  Int J Colorectal Dis       Date:  2004-07-27       Impact factor: 2.571

3.  Cholecystokinin octapeptide improves cardiac function by activating cholecystokinin octapeptide receptor in endotoxic shock rats.

Authors:  Xiao-Yun Zhao; Yi-Ling Ling; Yu-Guang Li; Ai-Hong Meng; Han-Ying Xing
Journal:  World J Gastroenterol       Date:  2005-06-14       Impact factor: 5.742

4.  Bolus injection of human UII in conscious rats evokes a biphasic haemodynamic response.

Authors:  Sheila M Gardiner; Julie E March; Philip A Kemp; Terence Bennett
Journal:  Br J Pharmacol       Date:  2004-08-31       Impact factor: 8.739

5.  Characterization of the receptors and mechanisms involved in the cardiovascular actions of sCCK-8 in the pithed rat.

Authors:  A J Gaw; D M Hills; C F Spraggs
Journal:  Br J Pharmacol       Date:  1995-06       Impact factor: 8.739

6.  Mediation by CCKB receptors of the CCK-evoked hyperaemia in rat gastric mucosa.

Authors:  A Heinemann; M Jocic; U Holzer-Petsche; G Pethö; B M Peskar; D C Horwell; P Holzer
Journal:  Br J Pharmacol       Date:  1995-10       Impact factor: 8.739

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.